Weill Cornell Medicine Events

Manufacturing Considerations in Drug Development: Seminar & 1:1

BioVenture eLab, a part of Weill Cornell Medicine Enterprise Innovation, invites WCM faculty and trainees working in drug development to join an educational program focused on designing an R&D and manufacturing plan for your innovation. Featuring Catalent Pharma Solutions, a renowned global CDMO that partners with pharma and biotech companies to accelerate and lead development, the program will include two presentations - one focused on biologics and another on small molecules. Following the presentations, the Catalent representatives will be available to meet 1:1 with you and your team to offer tailored mentoring for your specific project.
Presentations: 10-12pm (Hybrid)
  • Biologics Presentation: Strategic Considerations in Biologics CMC Development to Ensure Successful Path to IND

  • Small Molecules Presentation: Streamlining Formulation and Delivery of Small Molecules in Early Development

1:1 Meetings: 12:30-5pm (In-person) - You need to register for the program in order to schedule a 1:1 appointment.
This is a hybrid program where the presentation portion will take place at BioVenture eLab, 1157 York Ave, and will include a Zoom option. However, please note that 1:1 meetings will be in-person only and will be held at Belfer Research Building from 12:30-5pm.
Please RSVP using the eventbrite link.

Dial-In Information

Zoom will be sent to those who select virtual participation in the Eventbrite. Please see link below to RSVP

Thursday, November 30, 2023 at 10:00am to 12:00pm

BioVenture eLab, 1st floor 1157 York Ave

Event Type

Lecture/Seminar, Workshop, Information Session


Enterprise Innovation





Photo Alt Text

Manufacturing Considerations in Drug Development with Catalent

Is this a virtual event?


Virtual Event Registration URL


Google Calendar iCal Outlook

Recent Activity

You're not going yet!

This event requires registration.